Eidgenossische Technische Hochschule Zurich:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Eidgenossische Technische Hochschule Zurich - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9352
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Eidgenossische Technische Hochschule Zurich (ETH Zurich) is an educational service provider that offers studies in technology and the natural sciences. The university offers scientific education through bachelor programmes and master programmes in the areas of applied geophysics, architecture, biology, agricultural science, agroecosystem science, biomedical engineering, and food science among others. It offers research in various disciplines such as world food system, health, risk research, information processing, cities of the future, climate change, energy, new materials and industrial processes, through several competence centres. The university also provides continuing education services and other non degree courses. ETH Zurich is headquartered in Zurich, Switzerland.

Eidgenossische Technische Hochschule Zurich – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Eidgenossische Technische Hochschule Zurich, Medical Devices Deals, 2012 to YTD 2018 9
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Biognosys Enters into Licensing Agreement with ETH Zurich Foundation 11
Boehringer Ingelheim Enters Into Research Agreement With ETH Zurich 12
CovalX Enters Into Agreement With Swiss Federal Institute of Technologie For Epitope Mapping 13
Licensing Agreements 14
Biognosys Enters into Licensing Agreement with ETH Zurich Foundation 14
Dualsystems Biotech Enters Into Licensing Agreement With ETH Zurich For Ligand Receptor Capture Technology 15
Equity Offering 16
Versantis Spin Out from ETH Zurich 16
Eidgenossische Technische Hochschule Zurich – Key Competitors 17
Eidgenossische Technische Hochschule Zurich – Key Employees 18
Eidgenossische Technische Hochschule Zurich – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 19
Recent Developments 20
Government and Public Interest 20
Aug 06, 2018: Hidden signs in cancer tissue 20
Other Significant Developments 22
Aug 10, 2018: Targeting a brain mechanism could treat aggression 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Key Facts 2
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eidgenossische Technische Hochschule Zurich, Deals By Therapy Area, 2012 to YTD 2018 8
Eidgenossische Technische Hochschule Zurich, Medical Devices Deals, 2012 to YTD 2018 9
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Biognosys Enters into Licensing Agreement with ETH Zurich Foundation 11
Boehringer Ingelheim Enters Into Research Agreement With ETH Zurich 12
CovalX Enters Into Agreement With Swiss Federal Institute of Technologie For Epitope Mapping 13
Biognosys Enters into Licensing Agreement with ETH Zurich Foundation 14
Dualsystems Biotech Enters Into Licensing Agreement With ETH Zurich For Ligand Receptor Capture Technology 15
Versantis Spin Out from ETH Zurich 16
Eidgenossische Technische Hochschule Zurich, Key Competitors 17
Eidgenossische Technische Hochschule Zurich, Key Employees 18
Eidgenossische Technische Hochschule Zurich, Subsidiaries 19
Eidgenossische Technische Hochschule Zurich, Joint Venture 19

List of Figures
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Eidgenossische Technische Hochschule Zurich, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Eidgenossische Technische Hochschule Zurich:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Connell Limited Partnership:企業の戦略・SWOT・財務分析
    Connell Limited Partnership - Strategy, SWOT and Corporate Finance Report Summary Connell Limited Partnership - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Terma AS:企業の戦略・SWOT・財務情報
    Terma AS - Strategy, SWOT and Corporate Finance Report Summary Terma AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • PolyPid Ltd (POLY):医療機器:M&Aディール及び事業提携情報
    Summary PolyPid Ltd (PolyPid) is a pharmaceutical company that develops manufactures and commercializes therapies for the treatment of various medical conditions including infection, pain, inflammation and cancer. The company’s pipeline product candidates include D-Plex100, an antibiotic drug reserv …
  • Metro AG:戦略・SWOT・企業財務分析
    Metro AG - Strategy, SWOT and Corporate Finance Report Summary Metro AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Oasis Petroleum Inc (OASPQ):企業の財務・戦略的SWOT分析
    Oasis Petroleum Inc (OASPQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Owensboro Municipal Utilities:企業の発電所・SWOT分析2018
    Owensboro Municipal Utilities - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Kuoni Travel Holding Ltd.:企業の戦略・SWOT・財務情報
    Kuoni Travel Holding Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kuoni Travel Holding Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Isetan Mitsukoshi Holdings Ltd.:戦略・SWOT・企業財務分析
    Isetan Mitsukoshi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Isetan Mitsukoshi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Hutchison China Meditech Ltd:企業の戦略・SWOT・財務分析
    Hutchison China Meditech Ltd - Strategy, SWOT and Corporate Finance Report Summary Hutchison China Meditech Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Delek Group Ltd:企業のM&A・事業提携・投資動向
    Delek Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Delek Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • The KEYW Holding Corporation:企業のM&A・事業提携・投資動向
    The KEYW Holding Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The KEYW Holding Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Graham Holdings Company:企業の戦略・SWOT・財務情報
    Graham Holdings Company - Strategy, SWOT and Corporate Finance Report Summary Graham Holdings Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Howden Joinery Group Plc:企業の戦略・SWOT・財務情報
    Howden Joinery Group Plc - Strategy, SWOT and Corporate Finance Report Summary Howden Joinery Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Manulife Financial Corporation:企業のM&A・事業提携・投資動向
    Manulife Financial Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Manulife Financial Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • UGI Corporation (UGI)-石油・ガス分野:企業M&A・提携分析
    Summary UGI Corporation (UGI) is a holding company providing energy products and services. Through a network of subsidiaries, the company stores, transports, distributes and markets energy products and related services. It serves as a domestic and international retail distributor of propane and buta …
  • Streamline Health Solutions Inc (STRM):企業の財務・戦略的SWOT分析
    Summary Streamline Health Solutions Inc (Streamline Health) is a provider of in revenue cycle management. The company offers patient engagement and SaaS-based solutions. Its portfolio of services includes Health Information Management (HIM), patient care, patient engagement, coding and Clinical Docu …
  • TTM Technologies, Inc.:企業の戦略・SWOT・財務情報
    TTM Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary TTM Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Conversant Intellectual Property Management Inc.:企業のM&A・事業提携・投資動向
    Conversant Intellectual Property Management Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Conversant Intellectual Property Management Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descri …
  • Starpharma Holdings Ltd (SPL):医療機器:M&Aディール及び事業提携情報
    Summary Starpharma Holdings Ltd (Starpharma) is a biotechnology company, which researches, develops and manufactures dendrimer products for pharmaceutical, life sciences and other applications. Dendrimers are synthetic nanoscale polymers with pharmaceutical and medical uses. The company’s developmen …
  • Molnlycke Health Care AB-医療機器分野:企業M&A・提携分析
    Summary Molnlycke Health Care AB (Molnlycke) a subsidiary of Investor AB, is a medical device company. The company carries out the manufacturing and marketing of single-use surgical and wound care products. The company offers a range of surgical and wound care products; infection prevention solution …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆